The goal of this module is to assess patient-related barriers and clinician-held misconceptions that limit optimal schizophrenia treatment, and outline strategies to address/overcome them
The goal of this module is to outline best practices and guideline recommendations derived from clinical trial and real-world data for the therapeutic use of LAIs to optimize outcomes
The goal of this module is to outline patient-related barriers and clinician-held misconceptions that limit optimal schizophrenia treatment, and outline practical considerations to address/overcome them
Supported by independent educational grants from Alkermes, Inc and Teva Pharmaceuticals
Therapist/Owner, Recovery Now, LLC
Founder, Lead Clinician, Different MHP, PC
Department Chair, Psychiatry and Substance Abuse Disorders, Hope Health, University of South Carolina